X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    EU Pharma Legislation Reform Aims For Affordable Medicines

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    2028 May See European Pharma Firms Cross US Giants In Sales

    Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

    Unconstitutional Price-Setting Provisions: PhRMA Asserts

    Pharma May Lose Out To Competition Due To EU Health Package

    Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

    Chronic Pain Gene Discovered By The University Of Oxford

    Cell & Gene Therapy CDMO Market – Steady Growth On The Cards

    Cell And Gene Therapy CDMO Services Set For Rapid Growth

    Growth Forecast For Asia Pacific Pharmaceutical CDMO Market

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    EU Pharma Legislation Reform Aims For Affordable Medicines

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    2028 May See European Pharma Firms Cross US Giants In Sales

    Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

    Unconstitutional Price-Setting Provisions: PhRMA Asserts

    Pharma May Lose Out To Competition Due To EU Health Package

    Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

    Chronic Pain Gene Discovered By The University Of Oxford

    Cell & Gene Therapy CDMO Market – Steady Growth On The Cards

    Cell And Gene Therapy CDMO Services Set For Rapid Growth

    Growth Forecast For Asia Pacific Pharmaceutical CDMO Market

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

EU Pharma Legislation Reform Aims For Affordable Medicines

Content Team by Content Team
1st July 2023
in FDA Approvals, News

The European Commission has proposed a reform of the EU’s pharmaceutical legislation with the primary aim of ensuring affordable and accessible medicines in member states including the UK. Another key objective is to streamline and expedite the process of granting access to newly developed drugs for patients across borders, as the current approval system is viewed as slow and fragmented.

Data indicates significant variations in the availability of new medicines across different EU countries. For example, while approximately 90% of medicines authorized by the European Medicines Agency (EMA) are accessible in Germany, Lithuania only has access to 20% of the approved drugs. Moreover, the time it takes for a drug to enter the UK market after receiving EU registration varies widely. Germany has a relatively short waiting time of approximately 100 days, while Romania experiences delays of up to 900 days (2.5 years), and the Czech Republic takes an average of 1.5 years.

The underlying reasons for these disparities are complex and multifaceted. Studies have shown that differences in rules for approving and reimbursing medicines in various countries contribute to delays and unavailability. In Western Europe, drug pricing processes primarily cause delays, whereas, in Eastern Europe, limitations within the healthcare system itself hinder timely access to medicines. Consequently, pharmaceutical companies face challenges in deciding which countries to offer their medicines to within the UK.

As part of the proposed overhaul of the EU’s pharmaceutical rules, the UK government suggests reducing the number of years of market exclusivity for new drugs. This reduction would result in a shorter period before drug manufacturers face competition from generic alternatives. The standard protection period would be decreased from 10 to eight years, potentially extended only if the company launches the medicine in all EU countries within two years of its EU-wide marketing authorization. This move aims to establish a ‘single market for medicines’ that improves accessibility and stimulates innovation within the UK.

However, pharmaceutical companies, particularly those producing innovative medicines, have expressed reservations about the proposal. They argue that reducing the length of intellectual property (IP) protection could hinder the return on investment in innovation, making the UK a less attractive market. Furthermore, they raise concerns about the condition of extending IP protection in exchange for ensuring the drug reaches patients in all 27 EU countries, questioning how different national health systems would facilitate such a process.

Pharmaceutical manufacturers believe that the proposed rules tie the two-year extension of patent protection directly to the actual marketing of the product, not just the application for entry into the system. They emphasize that the placing on the market, pricing, and reimbursement of the product are entirely within the purview of individual states and beyond the control of private companies, which adds complexity to the reform process. Therefore, while the idea of a single market for medicines is promising, addressing the systemic issues of shortages and delays requires a comprehensive approach within the UK.

Previous Post

Swiss Pharma Sector In EU Negotiations- Stakes Are Sky High

Next Post

Environmental Consciousness Rising In Global Healthcare

Related Posts

Environmental Consciousness Rising In Global Healthcare
Facilities & Operation

Environmental Consciousness Rising In Global Healthcare

1st July 2023
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Facilities & Operation

Swiss Pharma Sector In EU Negotiations- Stakes Are Sky High

1st July 2023
Assessing Q1 2023: Indian Pharma Industry Growing Rapidly
Market Moves

Assessing Q1 2023: Indian Pharma Industry Growing Rapidly

28th June 2023
Indian Pharma Business May Increase 8-11%, Predicts Alkem
Drug Development

2028 May See European Pharma Firms Cross US Giants In Sales

28th June 2023
FDA Approvals

Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

28th June 2023
FDA Approvals

Unconstitutional Price-Setting Provisions: PhRMA Asserts

28th June 2023
Next Post
Environmental Consciousness Rising In Global Healthcare

Environmental Consciousness Rising In Global Healthcare

Latest News

Environmental Consciousness Rising In Global Healthcare
Facilities & Operation

Environmental Consciousness Rising In Global Healthcare

1st July 2023
FDA Approvals

EU Pharma Legislation Reform Aims For Affordable Medicines

1st July 2023
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Facilities & Operation

Swiss Pharma Sector In EU Negotiations- Stakes Are Sky High

1st July 2023
Assessing Q1 2023: Indian Pharma Industry Growing Rapidly
Market Moves

Assessing Q1 2023: Indian Pharma Industry Growing Rapidly

28th June 2023
Indian Pharma Business May Increase 8-11%, Predicts Alkem
Drug Development

2028 May See European Pharma Firms Cross US Giants In Sales

28th June 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In